Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Croma Aesthetics Canada is the Canadian subsidiary of the Austrian-based Croma-Pharma GmbH, a global leader in the minimally invasive aesthetics market. The company specializes in the development and distribution of high-quality hyaluronic acid fillers, polydioxanone (PDO) lifting threads, and advanced skincare products. Their flagship product line, Saypha, is widely used by healthcare professionals for facial rejuvenation and volume restoration. Additionally, the company provides medical practitioners with access to botulinum toxin treatments and comprehensive clinical training. Croma Aesthetics Canada is dedicated to advancing the aesthetic field through innovative products and educational support for the Canadian medical community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Croma Aesthetics Canada.